Which material does the TB-500 label refer to?
Supply the intended sequence or product specification if available. A TB-500 fragment and a full-length thymosin beta-4 target must not be treated as interchangeable identities. The expected target and reporting basis need to be agreed before interpreting a molecular-mass result.
Also listed as: Thymosin beta-4 fragment. Confirm the intended form from the specification.
Information to include
Transcribe the complete label, including any fragment designation, and provide the supplier specification rather than only the short name.
- Ship lyophilized powder rather than reconstituted solution wherever possible
- Keep the vial sealed and protected from light and heat in transit
- State the nominal amount per vial and whether the vial has been opened
Method and reporting scope
Roughly under 1.5 kDa. Runs well on a standard reversed-phase gradient with low-ultraviolet detection, and gives clean, easily read comparisons against reference spectra.
Area purity by HPLC-UV, identity against reference spectra, verifiable COA. Reference availability and sample suitability are confirmed before acceptance. Read the method and reporting information for the techniques in your quote.
Price, timing and submission
The starting panel is $250 CAD. Volume rates, optional fees and tax are shown separately. Standard peptide analysis typically takes 5-10 business days after receipt and acceptance; other scopes are confirmed in the quote.
Wait for the quantity and mailing instructions before shipping. A report describes the sample tested. Testing one vial does not characterize every unit in a batch.
Useful reading for this sample
- Understand the testing question and report
- Sample and packing requirements
- Identity confirmation for a labelled sample
Define the reporting scope before shipping
Tell us whether you need identity, area purity, measured content or a contaminant result. Include the complete label, supplier lot, sample form and any preparation history. The accepted request confirms method suitability, quantity, price and timing.
Content and label-claim testing · Evidence and reporting controls · Prices and volume rates
Technical references
These sources explain the analytical concepts. They do not certify CPT or validate a particular sample result.
- ICH Q2(R2): Validation of Analytical Procedures
General principles for evaluating whether an analytical procedure is suitable for its intended measurement.
- FDA: Analytical Procedures and Methods Validation for Drugs and Biologics
Background on reference standards, analytical procedures and supporting validation information.